Search

Author/Creator Buchmann, T.

2. Α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas. Issue 1 (4th March 2019)

Authors:
Dodagatta-Marri, E.; Meyer, D. S.; Reeves, M. Q.; Paniagua, R.; To, M. D.; Binnewies, M.; Broz, M. L.; Mori, H.; Wu, D.; Adoumie, M.; Del Rosario, R.; Li, O.; Buchmann, T.; Liang, B.; Malato, J.; Arce Vargus, F.; Sheppard, D.; Hann, B. C.; Mirza, A.; Quezada, S. A.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search